INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 01, 2012 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 10,428 | $15.64 | 30,134 |
| Aug 01, 2012 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 10,428 | -- | -- |
| Dec 15, 2016 |
Director, President Regeneron Laboratori
Trans History: 673
|
Director, President Regeneron Laboratori | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 10,429 | $380.09 | 686,571 |
| Jul 13, 2011 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Open market or private sale of non-derivative or derivative security | 10,438 | $56.71 | 176,155 |
| Jul 01, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 10,463 | $296.38 | 20,504,135 |
| Sep 15, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 10,471 | $343.84 | 22,308,524 |
| Jun 21, 2017 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 10,493 | $510.02 | 32,256 |
| Jun 21, 2021 |
Director, President and Chief Scientific
Trans History: 673
|
Director, President and Chief Scientific | Form 4 | Open market or private sale of non-derivative or derivative security | 10,514 | $542.43 | 4,384 |
| Dec 26, 2006 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 10,529 | -- | 349,113 |
| Jan 27, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 10,537 | $271.82 | 15,836,959 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.